| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 8539- | Matr, | Matrine ameliorates cognitive deficits via inhibition of microglia mediated neuroinflammation in an Alzheimer's disease mouse model |
| - | in-vivo, | AD, | NA |
| 8559- | Matr, | Matrine induces toxicity in mouse liver cells through an ROS-dependent mechanism |
| - | vitro+vivo, | Nor, | NA |
| 8546- | Matr, | Matrine Attenuates Neurological Deficits and Neuroinflammation by Inhibiting the HMGB1/RAGE Axis and Ferroptosis in Intracerebral Hemorrhage Mice |
| - | in-vivo, | Stroke, | NA |
| 7824- | MBS, | IVT, | VT, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 8629- | MBZ, | Repurposing the antihelmintic mebendazole as a hedgehog inhibitor |
| - | in-vitro, | Nor, | NIH-3T3 | - | vitro+vivo, | GBM, | GL-15 | - | in-vitro, | GC, | DAOY |
| 8631- | MBZ, | BEV, | Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer |
| - | Trial, | CRC, | NA |
| 8636- | MBZ, | Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer |
| - | in-vivo, | Ovarian, | SKOV3 |
| 8637- | MBZ, | Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors |
| - | Trial, | MB, | NA |
| 8642- | MBZ, | In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning |
| - | vitro+vivo, | CRC, | HT-29 | - | NA, | NA, | MCF10 |
| 8643- | MBZ, | Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | 4T1 | - | in-vitro, | BC, | SUM159 |
| 8651- | MBZ, | Rad, | Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma |
| - | in-vitro, | Var, | NA |
| 8648- | MBZ, | Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature |
| - | Review, | Var, | NA |
| 8784- | mCHEMO, | Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells |
| - | Review, | Var, | NA |
| 8785- | mCHEMO, | capec, | Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
| - | Trial, | NPC, | NA |
| 2486- | mCHEMO, | capec, | Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases |
| - | Case Report, | HCC, | NA |
| 2488- | mCHEMO, | Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma |
| - | in-vitro, | HCC, | HUH7 | - | in-vivo, | HCC, | NA |
| 2489- | mCHEMO, | capec, | Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma |
| - | Case Report, | HCC, | NA |
| 8815- | MCP, | Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension |
| - | Trial, | Nor, | NA |
| 8814- | MCP, | Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study |
| - | Trial, | Pca, | NA |
| 8822- | MCP, | Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3 |
| - | vitro+vivo, | CRC, | T24/HTB-9 | - | in-vitro, | Bladder, | J82 |
| 8823- | MCP, | Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model |
| - | in-vivo, | CRC, | CT26 |
| 8824- | MCP, | Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study |
| - | Trial, | Var, | NA |
| 8621- | MCT, | Metabolic targeting of pantothenate by medium chain fats in glioblastoma cells |
| - | Study, | GBM, | U251 |
| 2644- | MCT, | The Effects of Medium-Chain Triglyceride Oil Supplementation on Endurance Performance and Substrate Utilization in Healthy Populations: A Systematic Review |
| - | Review, | Nor, | NA |
| 8723- | MeJa, | Methyl Jasmonate Reduces Inflammation and Oxidative Stress in the Brain of Arthritic Rats |
| - | in-vivo, | Arthritis, | NA |
| 8755- | MeSA, | The Inhibitory Efficacy of Methylseleninic Acid Against Colon Cancer Xenografts in C57BL/6 Mice |
| - | in-vivo, | CRC, | NA |
| 8707- | MET, | Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 8708- | MET, | Tumour, whole-blood, plasma and tissue concentrations of metformin in lung cancer patients |
| - | Human, | Lung, | NA |
| 8709- | MET, | Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer |
| - | Trial, | BC, | NA |
| 8712- | MET, | Metformin Active Surveillance Trial in Low-Risk Prostate Cancer |
| - | Trial, | Pca, | NA |
| 8713- | MET, | Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol |
| - | Trial, | Pca, | NA |
| 2385- | MET, | Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model |
| - | in-vitro, | AD, | H4 | - | in-vitro, | NA, | HEK293 | - | in-vivo, | NA, | NA | - | in-vitro, | NA, | SH-SY5Y |
| 5804- | MET, | NIV, | Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up. |
| - | Case Report, | PC, | NA |
| 5533- | MF, | Magnetic field-induced drug permeability in liposome vesicles |
| - | in-vitro, | Nor, | NA |
| 5532- | MF, | Magnetoporation: New Method for Permeabilization of Cancerous Cells to Hydrophilic Drugs |
| - | in-vivo, | BC, | NA |
| 5531- | MF, | Effect of low frequency, low amplitude magnetic fields on the permeability of cationic liposomes entrapping carbonic anhydrase: I. Evidence for charged lipid involvement |
| - | in-vitro, | Var, | NA |
| 2250- | MF, | MNPs, | Confronting stem cells with surface-modified magnetic nanoparticles and low-frequency pulsed electromagnetic field |
| - | Review, | Var, | NA |
| 8491- | MF, | Chemo, | Chemotherapy of human carcinoma xenografts during pulsed magnetic field exposure |
| - | in-vivo, | CRC, | HT-29 | - | NA, | Melanoma, | A431 |
| 8489- | MF, | Pulsed electromagnetic fields induce ferroptosis in osteosarcoma cells and promote osteogenic differentiation |
| - | in-vitro, | OS, | U2OS | - | in-vitro, | OS, | MG63 |
| 8488- | MF, | Efficacy and Durability of Repetitive Transcranial Magnetic Stimulation on Cognitive Function in Patients With Mild-to-Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis |
| - | Review, | AD, | NA |
| 8487- | MF, | The effect of repetitive transcranial magnetic stimulation on immediate and long-term cognitive functions in Alzheimer's dementia and mild cognitive impairment: a meta-analysis |
| - | Review, | AD, | NA |
| 8485- | MF, | doxoR, | Static magnetic field promotes the doxorubicin toxicity effects on osteosarcoma cells |
| - | in-vitro, | OS, | G292 |
| 8484- | MF, | doxoR, | Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells |
| - | in-vitro, | BC, | MDA-MB-231 |
| 7390- | MF, | A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP |
| 7387- | MF, | Effects of Sinusoidal Magnetic Field Observed on Cell Proliferation, Ion Concentration, and Osmolarity in Two Human Cancer Cell Lines |
| - | in-vitro, | AML, | HL-60 | - | in-vitro, | adrenal, | SK-HEP-1 |
| 7384- | MF, | Reactive oxygen species (ROS) production in HepG2 cancer cell line through the application of localized alternating magnetic field |
| - | in-vitro, | Liver, | HepG2 |
| 7383- | MF, | Magneto mitochondrial dysfunction mediated cancer cell death using intracellular magnetic nano-transducers |
| - | vitro+vivo, | Var, | NA |
| 7391- | MF, | The effects of pulsed magnetic field exposure on the permeability of leukemia cancer cells |
| - | in-vitro, | AML, | K562 |
| 6938- | MF, | Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model |
| - | in-vivo, | BPH, | NA |
| 6937- | MF, | Noninvasive treatment for men suffering from enlarged prostate |
| - | Review, | BPH, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid